Radiation recall dermatitis induced by erlotinib

Journal of the American Academy of Dermatology

Volumn 61, Issue 6, 2009, Pages 1086-

  Dauendorffer, Jean Noël ^a   Dupuy, Alain ^b  

^a Department of Dermatology   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ERLOTINIB; GEMCITABINE;

AGED; ANAMNESIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; COLON ADENOCARCINOMA; DRUG ERUPTION; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; MASTECTOMY; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RECALL DERMATITIS;

AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RADIODERMATITIS;

EID: 71649105997     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.04.033     Document Type: Article

References (5)

1. Ristić B. Radiation recall dermatitis. Int J Dermatol 43 (2004) 627-631
2. Hird A.E., Wilson J., Symons S., Sinclair E., Davis M., and Chow E. Radiation recall dermatitis: case report and review of the literature. Curr Oncol 15 (2008) 53-62
3. Heidary N., Naik H., and Burgin S. Chemotherapeutic agents and the skin: an update. J Am Acad Dermatol 58 (2008) 545-570
4. Gerber P.A., Enderlein E., Homey B., Muller A., Boelke E., and Budach W. Radiation-induced prevention of erlotinib-induced skin rash is transient: a new aspect toward the understanding of epidermal growth factor receptor inhibitor associated cutaneous adverse effects. J Clin Oncol 25 (2007) 4697-4698
5. Yalçin S., Dizdar O., Yalçin B., and GöKöz O. Sparing of previously irradiated skin from erlotinib-induced acneiform rash. J Am Acad Dermatol 58 (2008) 178-179